Développement de deux plateformes pharmaceutiques gélifiées : un hydrogel de nanocapsules lipidiques et un organogel avec le même agent de réticulation

Abstract : An innovative hydrogel platform obtained by the association of lipid nanocapsules (LNCs) was based on the previous work on modified gemcitabine. To limit the inherent toxicity of the hydrogel, gemcitabine was replaced by cytidine, then modified by an aliphatic chain (Cyt-C16). The hydrogel network was allowed by H-bond interactions between cytidine moieties exposed at the oil/water interfaces of LNCs. An experimental plan provided the formulation processes for 4 optimized sizes of model LNCs. The gelation was only possible for LNC sizes higher than 50 nm, and the hydrogel viscoelastic properties are versatile. The hydrogel is more “rigid” when LNC and Cyt-C16 concentrations increase, independently of the LNC size. The hydrogels are injectable and allow a sustained release of LNCs (withmonodisperse size), without additional in vitrocytotoxicity due to Cyt-C16. Moreover, when solubilized in oil, Cyt-C16 alone produced an organogel platform, whose viscoelastic properties are strengthened increasing its concentration. Both types of gels showed a good biocompatibility after an in vivo subcutaneous (SC) injection, with a local inflammatory response similar to that of induced by an approved excipient. These two forms could be used to sustain the release of various drugs, and two preclinical applications of hydrogels have been explored : one using the SC route to target lymph nodes, and the second for local treatment after glioblastoma resection.
Document type :
Theses
Complete list of metadatas

Cited literature [306 references]  Display  Hide  Download

https://tel.archives-ouvertes.fr/tel-02188202
Contributor : Abes Star <>
Submitted on : Thursday, July 18, 2019 - 12:06:07 PM
Last modification on : Friday, July 19, 2019 - 1:34:31 AM

File

these_PITORRE.pdf
Version validated by the jury (STAR)

Identifiers

  • HAL Id : tel-02188202, version 1

Citation

Marion Pitorre. Développement de deux plateformes pharmaceutiques gélifiées : un hydrogel de nanocapsules lipidiques et un organogel avec le même agent de réticulation. Médecine humaine et pathologie. Université d'Angers, 2017. Français. ⟨NNT : 2017ANGE0074⟩. ⟨tel-02188202⟩

Share

Metrics

Record views

228

Files downloads

46